136 related articles for article (PubMed ID: 24082086)
1. Reversible growth factor dependency and autonomy during murine myelomonocytic leukemia induced by oncogenes.
Metcalf D; Glaser SP; Xu Z; Di Rago L; Mifsud S
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17029-34. PubMed ID: 24082086
[TBL] [Abstract][Full Text] [Related]
2. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
[TBL] [Abstract][Full Text] [Related]
3. MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model.
Fu JF; Hsu CL; Shih LY
Int J Cancer; 2010 Apr; 126(7):1621-9. PubMed ID: 19711340
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
6. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.
Tomasson MH; Williams IR; Li S; Kutok J; Cain D; Gillessen S; Dranoff G; Van Etten RA; Gilliland DG
Blood; 2001 Mar; 97(5):1435-41. PubMed ID: 11222391
[TBL] [Abstract][Full Text] [Related]
7. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
Lavau C; Luo RT; Du C; Thirman MJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463
[TBL] [Abstract][Full Text] [Related]
8. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.
Li S; Gillessen S; Tomasson MH; Dranoff G; Gilliland DG; Van Etten RA
Blood; 2001 Mar; 97(5):1442-50. PubMed ID: 11222392
[TBL] [Abstract][Full Text] [Related]
10. Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.
Albouhair S; Morgado E; Lavau C
PLoS One; 2013; 8(8):e72261. PubMed ID: 23977266
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
12. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
13. Leukemic cells from murine myeloid leukemia display an intrinsic ability for autonomous proliferation.
Curtis DJ; Metcalf D; Alexander B; Begley CG
Exp Hematol; 2000 Jan; 28(1):36-45. PubMed ID: 10658675
[TBL] [Abstract][Full Text] [Related]
14. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
[TBL] [Abstract][Full Text] [Related]
15. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
[TBL] [Abstract][Full Text] [Related]
16. Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor.
Tweardy DJ; Morel PA; Mott PL; Glazer EW; Zeh HJ; Sakurai M
Blood; 1992 Jul; 80(2):359-66. PubMed ID: 1378315
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
18. Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells.
Horton SJ; Grier DG; McGonigle GJ; Thompson A; Morrow M; De Silva I; Moulding DA; Kioussis D; Lappin TR; Brady HJ; Williams O
Cancer Res; 2005 Oct; 65(20):9245-52. PubMed ID: 16230385
[TBL] [Abstract][Full Text] [Related]
19. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
Lotem J; Sachs L
Blood; 1988 Feb; 71(2):375-82. PubMed ID: 2447982
[TBL] [Abstract][Full Text] [Related]
20. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.
DiMartino JF; Ayton PM; Chen EH; Naftzger CC; Young BD; Cleary ML
Blood; 2002 May; 99(10):3780-5. PubMed ID: 11986236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
